Admin Control Panel

New Post | Settings | Change Layout | Edit HTML | Edit posts | Sign Out


March20 podcast Dr Hazen
anti-TMA pill in a year or 2 ? (scroll 12 mins)

Additional info:
MEBO Karen
at UK Findacure conf 2020

Scroll down and select country

MEBO Map Testing & Meetups

Full details :
want listed ? contact

MEBO - UBIOME study 2018



MEBO Gut Microbiome Study
"Microbial Basis of Systemic Malodor and PATM Conditions (PATM)"
Funded by uBiome Research Grant

"Microbial Basis of Systemic Malodor and PATM Conditions (PATM)"

Dynamics of the Gut Microbiota in
Idiopathic Malodor Production

Started May 2018 - Ongoing

Current people sent kits : 100/100
3 kits per person


Participation info : LINK English

MEBO Private Facebook Group
to join : go to
or contact
Join/Watch the weekly
BO Sufferers Podcasts



TMAU Petition world
TMAU UK end total:262
TMAU UK ends 23/01/20
TMAU Petition USA end total 204
USA : Moveon open
TMAU (Dominican)
Metabolomic Profiling Study

Start : Aug 2016
Stage 1 : 27 Canadian volunteers to test
Latest click here (26 oct) :
17 samples returned

Note : Stage 1 is Canada only.
Return cut-off date : passed
Analysis can take 6/8 weeks
Analysis start in/before Nov
MEBO Research is a
NORD Member Organization
See RareConnect TMAU

Popular Posts (last 30 days)

Upcoming get-togethers

Let us know if you want a meetup listed
Follow MeBOResearch on Twitter

Blog Archive

MEBO Metabolic Malodor Survey (international) for Dr Hazen click here
click to Read more/less

survey for ANYONE who identifies with METABOLIC MALODOR

begun : Oct20
end : no ending for now

Regular readers will know that Dr Stan Hazen et al at Cleveland Clinic are developing a TMA-blocker pill, as they proposed in a 2011 paper that TMAO is a factor in CVD. Recently Dr Hazen and colleagues contacted MEBO as they have always thought they could also help with TMAU. This survey is to give them an idea of the 'state of the community'. It is a "version 1". They may not even look (though they have access permission), but it could be useful to give them an overview of the community

MEBO had a zoom call with Dr Hazen and his team in October. Another zoom call is planned when they have time

This is a GOOGLE FORMS survey

short url for survey :

current participants : 113 (update 18dec20)

Thursday, June 26, 2008

Hepatic portal vein : an explanation

This is an attempt to explain how things absorbed from the gut end up in the hepatic portal vein awaiting assessment by the liver, before then entering the main circulation.

The body will do all it can to keep the main circulating blood as clean as possible. With regards to the things absorbed from the gut, it has 2 main ways of making sure the absorbed material is as clean as possible before entering the main circulation: The gut wall barrier, and the hepatic portal vein 'waiting room', which is where all the absorbed material ends up and is then procesed by the liver, usually by the xenobiotic enzymes altering them

1. The gut wall barrier: Simply stops molecules too big from being absorbed into the portal vein when working correctly.
2. The portal vein: You can think of it as a waiting line for a screening check by the liver, before entrance to the main circulation. These molecules will (usually) be absorbable size, and for the most part the xenobiotic enzymes of the liver will then alter (neutralizing) the 'baddies' and possibly activate the 'goodies' (if need be). Once assessed and altered by the liver, it then enters the main bloodstream.

It's probably not as simple as that, but in general that's probably what mostly happens.

contents of the gut >>
gut wall keeps molecules too big from being absorbed (this is where leaky gut is a concern) >>
then enters the hepatic portal vein awaiting assessment by the liver>>
then the liver alters/neutralizes/activates the molecules >>
only then enters the main circulation


Post a Comment